Strategic partnerships The organization actively partners with pharmaceutical companies (Telix Pharmaceuticals) and biotech firms (Pacific Marine Biotech) to advance patient education and access to treatments, signaling receptive doors for sponsor collaborations, joint webinars, and disease education programs.

Clinical education Recent initiatives include educational webinars on new treatments (TLX101-Px) and PCNSL developments, indicating strong demand for KOL-led content. This creates opportunities to offer sponsored education events, patient education resources, and physician training programs.

Medical advisory growth Expansion of the Medical Advisory Board with multiple appointments in 2026 suggests a commitment to clinical credibility and program expansion, creating touchpoints for sponsor-backed research grants, advisory roles, and clinical trial collaboration.

Digital outreach Existing tech stack (AWS, WordPress, Shopify, Google Cloud) and active online events indicate readiness for enhanced digital campaigns, donor/member acquisition, and paid media support targeting caregivers, survivors, and healthcare professionals.

Funding scale Annual revenue in the range of one to ten million with a focused nonprofit footprint and a lean staff suggests cost-conscious partnerships, sponsorship opportunities, and scalable philanthropy programs aligned with sponsor milestones and outcomes.